Steroid treatment with clot removal for severe stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether adding a steroid (methylprednisolone) to the standard clot-removal procedure can improve recovery in people with a severe, large stroke. It aims to reduce brain swelling and improve outcomes after the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have had a severe ischemic stroke (a type of stroke caused by a blocked blood vessel in the brain) within the last 24 hours.
- A brain scan shows a large blockage in a major artery, and you are scheduled for a procedure to remove the clot (called a thrombectomy).
- You were independent in daily activities before this stroke (able to walk and care for yourself).
- You do not have certain conditions like active bleeding, severe infection, or allergy to steroids or contrast dye.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether butylphthalide, given after a procedure to remove a blood clot from the brain, can help reduce dangerous brain swelling. If you've had a severe stroke and recently had a clot-removal procedure, this drug might improve your recovery.
This trial tests if giving a steroid (methylprednisolone) directly into the brain artery after successful clot removal improves recovery. It is for people who had a large stroke in the front part of the brain and got the clot out within 24 hours.
This study tests whether a medication called a GLP-1 receptor agonist (a type of drug used for diabetes) can improve recovery after a major stroke that was treated with a procedure to remove the blood clot. The goal is to see if this drug helps reduce further brain damage and improve outcomes.
This trial tests if a hibernation-like therapy can improve recovery after a stroke caused by a large blood clot in the brain. It is for people who are having a stroke and are scheduled for a procedure to remove the clot.
This trial tests if removing a large blood clot from the brain up to 3 days after a stroke improves recovery compared to standard medical care alone. It is for patients who have a severe stroke and are otherwise healthy enough for the procedure.
This trial tests whether adding a steroid medicine (methylprednisolone) to the standard procedure to remove a blood clot (thrombectomy) can improve recovery in people with large, severe strokes. The study aims to see if the steroid helps reduce brain swelling and improves outcomes.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.